Abbott Laboratories (ABT) — This healthcare company develops, manufactures and sells products worldwide and has been in a bull market for more than 20 years.
However, ABT has spent this year in the narrow trading range of $48 to $60 while earnings have continued to improve.
The healthcare sector is considered to be defensive and ABT is generally regarded as a leader of the group. The target for current purchases is $60 and S&P has a 12-month target of $65.
Get Sam Collins’ Daily Trader’s Alert e-mailed straight to your inbox each morning before the opening bell absolutely FREE!
In addition to getting instant access to his Trade of the Day, you’ll also receive, in the same e-mail, his Daily Market Outlook so you can start your day off right by positioning yourself for profits!
Click here today to sign up today for Sam’s FREE Daily Trader’s Alert!
Sam Collins is a registered, fee-based portfolio manager who may be contacted email@example.com. You can also check out an archive of some of his most recent market outlooks by clicking here.